Anixa Biosciences ANIX 深 沪
等待开盘 02-11 09:30:00 美东时间
2.97
-0.010
-0.34%
华盛通- 最 高3.035
- 今 开3.00
- 成交量 23.92万股
- 最 低 2.80
- 昨 收 2.98
- 总市值 9913.71万
- 52周最高 5.4566
- 市盈率 静 --
- 换手率 0.72%
- 52周最低 2.331
- 委 比 65.72%
- 总股本 3337.95万
- 历史最高 8.09
- 量 比 1.06
- 振 幅 7.89%
- 历史最低 1.33
- 每 手 1
- 风险率 0.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Anixa Biosciences startet Phase-1-Studie mit hoher CAR-T-Dosis bei Eierstockkrebs
Anixa Biosciences startet Phase-1-Studie mit hoher CAR-T-Dosis bei Eierstockkrebs Anixa Biosciences Inc. hat ein Update zur laufenden Phase-1-Studie einer CAR-T-Zelltherapie bei Eierstockkrebs bekanntgegeben. Das Unternehmen berichtet, dass mehrere Patientinnen in den niedrigen Dosierungsgruppen ein
02-09 21:01
EXCLUSIVE: Anixa Biosciences' Ovarian Cancer Drug Candidate Shows Longer Survival With No Major Safety Issues
Anixa Biosciences shares new data from its ovarian cancer trial, showing patients lived longer than expected with no serious safety concerns, as regulators approved a major dose increase.
02-09 20:31
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.
02-04 21:03
Anixa Biosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting
Anixa Biosciences Inc. Announces Date for Upcoming Annual Stockholders Meeting Anixa Biosciences Inc. will hold its annual meeting virtually on March 10, 2026. During the meeting, shareholders will be asked to vote on the election of director nominees to serve on the company's board, the approval on
01-29 05:17
BUZZ-U.S. STOCKS ON THE MOVE-Sysco, Corning, HCA Healthcare
BUZZ-U.S. STOCKS ON THE MOVE-Sysco, Corning, HCA Healthcare Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and Nasdaq advanced on Tuesday as investors parsed through a s
01-27 23:45
BUZZ-Anixa Biosciences rises after Mexico approves patent for breast cancer vaccine
BUZZ-Anixa Biosciences rises after Mexico approves patent for breast cancer vaccine ** Shares of San Jose-based cancer treatment developer Anixa Biosciences ANIX.O up 7.47% at $3.32 premarket ** Co says Mexican Institute of Industrial Property approved a patent for its experimental breast cancer vac
01-27 22:02
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
2025-12-15 15:30
D. Boral Capital Maintains Buy on Anixa Biosciences, Maintains $10 Price Target
D. Boral Capital analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.
2025-12-12 20:23
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
Patent Extends Protection for Novel Vaccine Targeting a Cancer Projected to Strike Nearly 300,000 U.S. Women in 2026 SAN JOSE, Calif., Nov. 12, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. (...
2025-11-12 22:00
